Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · see citing works

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · see citing works

Staging of alzheimer's disease-related neurofibrillary changes

Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357 · see citing works

A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau

Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · see citing works

Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms

Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,114 · see citing works

Tau pathology in Alzheimer disease and other tauopathies

Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037 · see citing works

Role of tau protein in both physiological and pathological conditions

AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005 · see citing works

Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17

Hong, M. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,003 · see citing works

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · see citing works

Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding

Biernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796 · see citing works

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769 · see citing works

Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738 · see citing works

A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

Greenberg, S. G., & Davies, P. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5827 · Cited by 732 · see citing works

The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein

Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P. (1999) · Nature · doi:10.1038/21650 · Cited by 721 · see citing works

Domains of tau Protein and Interactions with Microtubules

Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E.-M., & Mandelkow, E. (1994) · Biochemistry · doi:10.1021/bi00198a017 · Cited by 655 · see citing works

Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205

Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608 · see citing works

Proline-directed and non-proline-directed phosphorylation of PHF-tau

Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., & Ihara, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.823 · Cited by 557 · see citing works

Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.

Clark, L. N., Poorkaj, P., Wszolek, Z., Geschwind, D., Nasreddine, Z. S., Miller, B. L., Li, D., Payami, H., Awert, F., Markopoulou, K., et al. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.22.13103 · Cited by 488 · see citing works

Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly

Hasegawa, M., Smith, M. J., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01217-4 · Cited by 482 · see citing works

The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development.

Goedert, M., Jakes, R., Crowther, R. A., Six, J., Lübke, U., Vandermeeren, M., Cras, P., Trojanowski, J. Q., & Lee, V. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5066 · Cited by 446 · see citing works

New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry

Hanger, D. P., Betts, J. C., Loviny, T. L. F., Blackstock, W. P., & Anderton, B. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062465.x · Cited by 378 · see citing works

Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum

Mesulam, M. M., Shaw, P. L., Mash, D. C., & Weıntraub, S. (2004) · Annals of Neurology · doi:10.1002/ana.20100 · Cited by 365 · see citing works

Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations

Alonso, A. D. C., Mederlyova, A., Novák, M., Grundke, I., & Iqbal, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405131200 · Cited by 330 · see citing works

Phosphorylation of microtubule‐associated protein tau: identification of the site for Ca2(+)‐calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles.

Steiner, B., Mandelkow�, E., Biernat, J., Gustke, N., Meyer, H. E., Schmidt, B., Mieskes, G., Söling, H., Drechsel, D. N., & Kirschner, M. W. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07563.x · Cited by 304 · see citing works

Tau Pathology in Two Dutch Families with Mutations in the Microtubule-Binding Region of Tau

Spillantini, M. G., Crowther, R. A., Kamphorst, W., Heutink, P., & Swieten, J. C. V. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65721-5 · Cited by 293 · see citing works

Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.

Paudel, H. K., Lew, J., Ali, Z., & Wang, J. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49492-1 · Cited by 285 · see citing works

Microtubule Dynamics: Mechanism, Regulation, and Function

Gelfand, V. I., & Bershadsky, A. D. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.000521 · Cited by 228 · see citing works

14-3-3ζ Is an Effector of Tau Protein Phosphorylation

Hashiguchi, M., Sobue, K., & Paudel, H. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003738200 · Cited by 223 · see citing works

cAMP-Dependent Protein Kinase Phosphorylations on Tau in Alzheimer’s Disease

Jicha, G. A., Weaver, C. L., Lane, E., Vianna, C., Kress, Y., Rockwood, J. M., & Davies, P. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07486.1999 · Cited by 207 · see citing works

Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly.

Scott, C. W., Spreen, R. C., Herman, J. L., Chow, F. P., Davison, M. D., Young, J., & Caputo, C. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54055-2 · Cited by 200 · see citing works

Abnormal Tau-Containing Filaments in Neurodegenerative Diseases

Crowther, R. A., & Goedert, M. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4270 · Cited by 185 · see citing works

Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles

Spillantini, M. G., Crowther, R. A., & Goedert, M. (1996) · Acta Neuropathologica · doi:10.1007/s004010050487 · Cited by 160 · see citing works

Glycogen Synthase Kinase 3β Phosphorylates Alzheimer's Disease-Specific Ser³⁹⁶ of Microtubule-Associated Protein Tau by a Sequential Mechanism

Li, T., & Paudel, H. K. (2006) · Biochemistry · doi:10.1021/bi051634r · Cited by 140 · see citing works

Cyclin-Dependent Protein Kinase 5 Primes Microtubule-Associated Protein Tau Site-Specifically for Glycogen Synthase Kinase 3β

Li, T., Hawkes, C. A., Qureshi, H. Y., Kar, S., & Paudel, H. K. (2006) · Biochemistry · doi:10.1021/bi051635j · Cited by 139 · see citing works

Distinct FTDP-17 Missense Mutations in Tau Produce Tau Aggregates and Other Pathological Phenotypes in Transfected CHO Cells

Vogelsberg-Ragaglia, V., BRUCE, J. S., Richter‐Landsberg, C., Zhang, B., Hong, M., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4093 · Cited by 129 · see citing works

Glycogen Synthase Kinase-3β Is Complexed with Tau Protein in Brain Microtubules

Sun, W., Qureshi, H. Y., Cafferty, P. W., Sobue, K., Agarwal-Mawal, A., Neufield, K. D., & Paudel, H. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107182200 · Cited by 110 · see citing works

Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology

Bronner, I. F., ter Meulen, B. C., Azmani, A., Severijnen, L.-A. W. F. M., Willemsen, R., Kamphorst, W., Ravid, R., Heutink, P., & Swieten, J. C. V. (2005) · Brain · doi:10.1093/brain/awh591 · Cited by 95 · see citing works

Expression of ?2-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells

Marzolo, M., Rommy von Bernhardi, M., Bu, G., & Inestrosa, N. C. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000501)60:3 · Cited by 87 · see citing works

14-3-3 Binds to and Mediates Phosphorylation of Microtubule-associated Tau Protein by Ser9-phosphorylated Glycogen Synthase Kinase 3β in the Brain

Yuan, Z., Agarwal-Mawal, A., & Paudel, H. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308298200 · Cited by 86 · see citing works

Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

Matsumura, N., Yamazaki, T., & Ihara, Y. (1999) · American Journal of Pathology · doi:10.1016/s0002-9440(10)65420-x · Cited by 81 · see citing works

The FTDP‐17‐Linked Mutation R406W Abolishes the Interaction of Phosphorylated Tau with Microtubules

Pérez, M., Lim, F., Arrasate, M., & Ávila, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742583.x · Cited by 80 · see citing works

Phosphorylation by Neuronal cdc2-like Protein Kinase Promotes Dimerization of Tau Protein in Vitro

Paudel, H. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28328 · Cited by 73 · see citing works

Abnormal tau species are produced during Alzheimer's disease neurodegenerating process

Flament, S., & Delacourte, A. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81337-7 · Cited by 66 · see citing works

Interaction of Neuronal Cdc2-like Protein Kinase with Microtubule-associated Protein Tau

Sobue, K., Agarwal-Mawal, A., Li, W., Sun, W., Miura, Y., & Paudel, H. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000784200 · Cited by 64 · see citing works

Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene

Arima, K., Kowalska, A., Hasegawa, M., Mukoyama, M., Watanabe, R., Kawai, M., Takahashi, K., Iwatsubo, T., Tabira, T., & Sunohara, N. (2000) · Neurology · doi:10.1212/wnl.54.9.1787 · Cited by 59 · see citing works

Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene

Wszołek, Z. K., Tsuboi, Y., Uitti, R. J., & Reed, L. A. (2000) · Neurology · doi:10.1212/wnl.55.12.1939 · Cited by 57 · see citing works

Neuronal Cdc2-like Protein Kinase (Cdk5/p25) Is Associated with Protein Phosphatase 1 and Phosphorylates Inhibitor-2

Agarwal-Mawal, A., & Paudel, H. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010002200 · Cited by 53 · see citing works

Mutant (R406W) Human Tau Is Hyperphosphorylated and Does Not Efficiently Bind Microtubules in a Neuronal Cortical Cell Model*

Krishnamurthy, P., & Johnson, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311203200 · Cited by 52 · see citing works

Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type

Flament, S., Delacourte, A., Delaère, P., Duyckaerts, C. J., & Hauw, J. (1990) · Acta Neuropathologica · doi:10.1007/bf00308927 · Cited by 51 · see citing works

Phosphorylation of Protein Phosphatase 1 by Cyclin-dependent Protein Kinase 5 during Nerve Growth Factor-induced PC12 Cell Differentiation

Li, T., Chalifour, L. E., & Paudel, H. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606347200 · Cited by 47 · see citing works

Effects of FTDP‐17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3β identified by mass spectrometry demonstrate certain mutations exert long‐range conformational changes

Connell, J. W., Gibb, G., Betts, J. C., Blackstock, W. P., Gallo, J., Lovestone, S., Hutton, M., & Anderton, B. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02267-0 · Cited by 42 · see citing works

Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells

Mack, T. G. A., Dayanandan, R., van Slegtenhorst, M., Whone, A. L., Hutton, M. L., Lovestone, S., & Anderton, B. H. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00434-1 · Cited by 26 · see citing works

Tau Released from Paired Helical Filaments with Formic Acid or Guanidine Is Susceptible to Calpain‐Mediated Proteolysis

Yang, L., Gordon‐Krajcer, W., & Ksiȩżak-Reding, H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041548.x · Cited by 24 · see citing works

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1 · see citing works

Physiological and pathological phosphorylation of tau by Cdk5

Kimura, T., Ishiguro, K., & Hisanaga, S. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00065 · Cited by 297 · see citing works

Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability

Alonso, A. D., Cohen, L. S., Corbo, C., Morozova, V., ElIdrissi, A., Phillips, G., & Kleiman, F. E. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00338 · Cited by 278 · see citing works

Protein phosphorylation in neurodegeneration: friend or foe?

Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252 · see citing works

Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo

Cowan, C. M., Bossing, T., Page, A., Shepherd, D., & Mudher, A. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0716-8 · Cited by 156 · see citing works

Nobiletin, a Citrus Flavonoid, Ameliorates Cognitive Impairment, Oxidative Burden, and Hyperphosphorylation of Tau in Senescence-Accelerated Mouse

Nakajima, A., Aoyama, Y., Nguyen, T.-T. L., Shin, E.-J., Kim, H.-C., Yamada, S., Nakai, T., Nagai, T., Yokosuka, A., Mimaki, Y., et al. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.05.025 · Cited by 115 · see citing works

Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation

Ambegaokar, S. S., & Jackson, G. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr432 · Cited by 113 · see citing works

Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro

Qureshi, H. Y., & Paudel, H. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178905 · Cited by 89 · see citing works

Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer’s Brains

Ono, M., Hayashi, S., Matsumura, K., Kimura, H., Okamoto, Y., Ihara, M., Takahashi, R., Mori, H., & Saji, H. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200002t · Cited by 83 · see citing works

Interaction of 14-3-3ζ with Microtubule-Associated Protein Tau within Alzheimer’s Disease Neurofibrillary Tangles

Qureshi, H. Y., Li, T., MacDonald, R., Cho, C., Leclerc, N. M., & Paudel, H. K. (2013) · Biochemistry · doi:10.1021/bi400442d · Cited by 79 · see citing works

Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease

Kumar, P., Jha, N. K., Jha, S. K., Ramani, K., & Ambasta, R. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140933 · Cited by 67 · see citing works

Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies

Nakajima, A., Ohizumi, Y., & Yamada, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.2.75 · Cited by 64 · see citing works

Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down Syndrome

Cárdenas, A. M., Ardiles, Á. O., Barraza, N., Báez‐Matus, X., & Caviedes, P. A. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.012 · Cited by 63 · see citing works

Cellular factors modulating the mechanism of tau protein aggregation

Fontaine, S. N., Sabbagh, J. J., Baker, J. D., Licha, C. R. M., Darling, A. L., & Dickey, C. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1839-9 · Cited by 60 · see citing works

Early Growth Response 1 (Egr-1) Regulates Phosphorylation of Microtubule-associated Protein Tau in Mammalian Brain

Lu, Y., Li, T., Qureshi, H. Y., Han, D. C., & Paudel, H. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220962 · Cited by 53 · see citing works

Amelioration of Tau pathology and memory deficits by targeting 5-HT7 receptor

Labus, J., Röhrs, K., Ackmann, J., Varbanov, H., Müller, F. E., Jia, S., Jahreis, K., Vollbrecht, A.-L., Butzlaff, M., Schill, Y., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101900 · Cited by 50 · see citing works

Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A

Li, L., Liu, Z., Liu, J., Tai, X., Hu, X., Liu, X., Wu, Z., Zhang, G., Shi, M., & Zhao, G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.002 · Cited by 50 · see citing works

Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast

Vanhelmont, T., Vandebroek, T., Vos, A. D., Terwel, D., Lemaire, K., Anandhakumar, J., Franssens, V., Swinnen, E., LEUVEN, F. V., & Winderickx, J. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00662.x · Cited by 49 · see citing works

Overexpression of 14-3-3ζ Promotes Tau Phosphorylation at Ser262 and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons

Qureshi, H. Y., Han, D. C., MacDonald, R., & Paudel, H. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084615 · Cited by 44 · see citing works

Kinase–Kinase Interaction and Modulation of Tau Phosphorylation

Hashiguchi, M., & Hashiguchi, T. (2012) · International review of cytology · doi:10.1016/b978-0-12-405210-9.00004-7 · Cited by 42 · see citing works

Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention

Kishinevsky, A. C. S., & Lou, J. K. I. W. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.s10-007 · Cited by 42 · see citing works

α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies

Padilla-Godínez, F. J., Vázquez-García, E. R., Trujillo-Villagrán, M. I., Soto-Rojas, L. O., Palomero‐Rivero, M., Hernández-González, O., Pérez-Eugenio, F., Collazo-Navarrete, O., Arias-Carrión, Ó., & Guerra‐Crespo, M. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1570553 · Cited by 42 · see citing works

Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer’s disease

Matsumura, K., Ono, M., Yoshimura, M., Kimura, H., Watanabe, H., Okamoto, Y., Ihara, M., Takahashi, R., & Saji, H. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.02.054 · Cited by 33 · see citing works

Hypoxia alters expression of Zebrafish Microtubule-associated protein Tau (mapta, maptb) gene transcripts

Nik, S. H. M., Newman, M., Ganesan, S., Chen, M., Martins, R. N., Verdile, G., & Lardelli, M. T. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-767 · Cited by 30 · see citing works

Elevated Levels of Soluble Total and Hyperphosphorylated Tau Result in Early Behavioral Deficits and Distinct Changes in Brain Pathology in a New Tau Transgenic Mouse Model

Flunkert, S., Hierzer, M., Löffler, T., Rabl, R., Neddens, J., Duller, S., Schofield, E., Ward, M. A., Posch, M., Jungwirth, H., et al. (2012) · Neurodegenerative Diseases · doi:10.1159/000338152 · Cited by 30 · see citing works

Interaction Between Eye Pigment Genes and Tau-Induced Neurodegeneration in<i>Drosophila melanogaster</i>

Ambegaokar, S. S., & Jackson, G. R. (2010) · Genetics · doi:10.1534/genetics.110.119545 · Cited by 30 · see citing works

Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease

Zussy, C., John, R., Urgin, T., Otaegui, L., Vigor, C., Acar, N., Canet, G., Vitalis, M., Morin, F., Planel, E., et al. (2022) · Antioxidants · doi:10.3390/antiox11050838 · Cited by 25 · see citing works

Impact of the Hereditary P301L Mutation on the Correlated Conformational Dynamics of Human Tau Protein Revealed by the Paramagnetic Relaxation Enhancement NMR Experiments

Kawasaki, R., & Tate, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113920 · Cited by 23 · see citing works

Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia

Guisle, I., Canet, G., Petry, S., Fereydouni-Forouzandeh, P., Morin, F., Kérauden, R., Whittington, R. A., Calon, F., Hébert, S. S., & Planel, E. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.02.011 · Cited by 23 · see citing works

Analysis of mutations in primary and metastatic synovial sarcoma

Xing, Z., Wei, L., Jiang, X., Conroy, J. M., Glenn, S. T., Bshara, W., Yu, T., Pao, A., Tanaka, S., Kawai, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26416 · Cited by 23 · see citing works

Stable Mutated tau441 Transfected SH-SY5Y Cells as Screening Tool for Alzheimer’s Disease Drug Candidates

Löffler, T., Flunkert, S., Taub, N., Schofield, E., Ward, M. A., Windisch, M., & Hutter‐Paier, B. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9716-6 · Cited by 22 · see citing works

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease

Lauterbach, E. C., Fontenelle, L. F., & Teixeira, A. L. (2011) · Parkinson s Disease · doi:10.1155/2012/753548 · Cited by 21 · see citing works

14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells

Li, T., & Paudel, H. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160635 · Cited by 21 · see citing works

Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice

Höllerhage, M., Deck, R., Andrade, A. D., Respondek, G., Xu, H. W., Rösler, T. W., Salama, M., Carlsson, T., Yamada, E. S., El-Hak, S. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113557 · Cited by 19 · see citing works

Hypoxic ischemia and proteasome dysfunction alter tau isoform ratio by inhibiting exon 10 splicing

Suh, J., Im, D. S., Moon, G. J., Ryu, K.-S., de Silva, R., Choi, I. S., Lees, A. J., Guénette, S. Y., Tanzi, R. E., & Gwag, B. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06732.x · Cited by 13 · see citing works

HS3ST2 expression induces the cell autonomous aggregation of tau

Huynh, M. B., Rebergue, N., Merrick, H., Gómez-Henao, W., Jospin, E., Biard, D. S. F., & Papy-García, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-13486-6 · Cited by 13 · see citing works

Regenerating islet-derived 1α (REG-1α) protein increases tau phosphorylation in cell and animal models of tauopathies

Moussaed, M., Huc-Brandt, S., Cubedo, N., Silhol, M., Murat, S., Lebart, M., Kovács, G. G., Verdier, J., Trousse, F., Rossel, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.029 · Cited by 11 · see citing works

A New Strategy for Preventive and Functional Therapeutic Methods for Dementia —Approach Using Natural Products—

Ohizumi, Y. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00245 · Cited by 10 · see citing works

Biomolecular phase separation of microtubule-associated protein tau and its role in the genesis of brain disorders

Bhandari, A. K., Dhami, A. S., Hemanthlumar, R. T., Mishra, N., Joslyn, B., Roy, S., Srinivasan, J., Prajapati, K. P., Kar, K., & Anand, B. G. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102879 · Cited by 3 · see citing works

Study of 3-O-sulfated heparan sulfates on tauopathy development in AD : neuropathologic and cellular approach

Rebergue, N. (2022) · theses.fr (ABES) · doi:10.70675/1625c958z4f5az4c53zb053z9743a765c9ac

BindingDB Entry 50043010: Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer's disease.

BindingDB (2014) · UC San Diego · doi:10.7270/q23j3fb2

Effect of FTDP-17 mutations on phosphorylation and dephosphorylation of tau protein in vitro

Han, D. (2007) · eScholarship@McGill (McGill) · doi:10.82308/6624

P3‐194: Effect of Pin1 and microtubule binding on dephosphorylation of FTDP‐17 mutant tau

Hisanaga, S. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.04.1068

Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly

Hasegawa, M., Smith, M. J., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01217-4 · Cited by 482 · see citing works

Heterogeneous phosphorylation of microtubule-associated protein tau in cultured cells

Kimura, T., Ishiguro, K., Hasegawa, M., & Hisanaga, S. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/conf.fncel.2016.36.00195

Effect of Pin1 or Microtubule Binding on Dephosphorylation of FTDP-17 Mutant Tau

Yotsumoto, K., Saito, T., Asada, A., Oikawa, T., Kimura, T., Uchida, C., Ishiguro, K., Uchida, T., Hasegawa, M., & Hisanaga, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003277 · Cited by 23 · see citing works